Merck (MRK) Divestments (2009 - 2021)
Merck (MRK) reported Divestments of -$82.0 million for Q2 2021, down 57.69% on a QoQ basis from -$52.0 million in Q1 2021.
Merck (MRK) has 7 years of Divestments data on file, last reported at -$82.0 million in Q2 2021.
- Quarterly Divestments changed N/A year-over-year to -$82.0 million in Q2 2021, while the trailing twelve-month figure through Mar 2022 was -$82.0 million (up 59.41% YoY) and the FY2021 annual result came in at -$134.0 million, up 46.4% from the prior year.
- Divestments declined to -$82.0 million in Q2 2021 per MRK's latest filing, from -$52.0 million in the prior quarter.
- Across five years, Divestments topped out at -$52.0 million in Q1 2021 and bottomed at -$82.0 million in Q2 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | - |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | - |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | - |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | - |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 312.00 Mn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -82.00 Mn |
| Mar 31, 2021 | -52.00 Mn |
| Dec 31, 2020 | -81.00 Mn |
| Sep 30, 2020 | -69.00 Mn |
| Dec 31, 2015 | 170.00 Mn |
| Sep 30, 2015 | 126.00 Mn |
| Jun 30, 2015 | 25.00 Mn |
| Dec 31, 2014 | 600.00 Mn |
| Jun 30, 2014 | 419.00 Mn |
| Mar 31, 2014 | 533.00 Mn |
| Dec 31, 2013 | 172.00 Mn |
| Dec 31, 2011 | -148.00 Mn |
| Sep 30, 2011 | 175.00 Mn |
| Jun 30, 2011 | 17.00 Mn |
| Mar 31, 2011 | 306.00 Mn |
| Sep 30, 2009 | 4.00 Bn |